| A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. |
| A genome-wide association study of monozygotic twin-pairs suggests a locus related to variability of serum high-density lipoprotein cholesterol. |
| A genome-wide scan for common variants affecting the rate of age-related cognitive decline. |
| A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. |
| An atlas of genetic influences on human blood metabolites. |
| APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. |
| Biological, clinical and population relevance of 95 loci for blood lipids. |
| Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. |
| Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. |
| Common variants at 30 loci contribute to polygenic dyslipidemia. |
| Discovery and refinement of loci associated with lipid levels. |
| Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. |
| Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. |
| Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. |
| Genetic variants influencing circulating lipid levels and risk of coronary artery disease. |
| Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. |
| Genome-wide association analysis of age-at-onset in Alzheimer's disease. |
| Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. |
| Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae. |
| Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy. |
| Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. |
| Genome-wide association study identifies multiple loci influencing human serum metabolite levels. |
| Genome-wide association study of Alzheimer's disease. |
| Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study. |
| Genome-wide characterization of shared and distinct genetic components that influence blood lipid levels in ethnically diverse human populations. |
| LDL-cholesterol concentrations: a genome-wide association study. |
| Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. |
| Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. |
| Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. |
| Newly identified loci that influence lipid concentrations and risk of coronary artery disease. |
| Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. |
| Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. |
| Seven new loci associated with age-related macular degeneration. |
| Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. |
| Sorl1 as an Alzheimer's disease predisposition gene? |
| THOC5: a novel gene involved in HDL-cholesterol metabolism. |